New Year, Same POTential
Cannabis stocks had another rough year in 2024, failing to make any meaningful progress or participate in the broader stock market’s rally. But, like all beaten-down industries, they occasionally pop back in the news like they did today. 📰
In late August, the industry’s biggest names and ETFs began rallying after a top official at the Department of Health and Human Services (HHS) wrote to Drug Enforcement Agency (DEA) Administrator Anne Milgram. In it, the official called for marijuana to be reclassified as a Schedule III drug under the Controlled Substances Act.Â